HIV-1 gp120: A Target for Therapeutics and Vaccine Design

E-ISSN： 1873-5592|17|1|122-135

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.1, 2016-01, pp. : 122-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycosylation of HIV-1 gp120 V3 Loop: Towards the Rational Design of a Synthetic Carbohydrate Vaccine

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3232-3242

Bentham Science Publishers

Access to resources Recommend Favorite

Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy

Current Medicinal Chemistry, Vol. 20, Iss. 6, 2013-01 ,pp. : 751-771

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Cations in the Interaction of Pradimicins with HIV-1 Envelope gp120

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 16, 2013-08 ,pp. : 1907-1915

Bentham Science Publishers

Access to resources Recommend Favorite

Conformational Properties of HIV-1 gp120/V3 Immunogenic Domains

Current Medicinal Chemistry, Vol. 12, Iss. 13, 2005-06 ,pp. : 1551-1568

Bentham Science Publishers

Access to resources Recommend Favorite

The GP120 Molecule of HIV-1 and its Interaction with T Cells

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 741-749

Bentham Science Publishers

Access to resources Recommend Favorite